PEPTIDE COMPARISON

Semax vs Selank

Two neuroactive research peptides compared without treating regional studies as settled evidence.

QUICK ANSWER

Semax vs Selank: the main difference.

Semax and Selank target different research questions and are not interchangeable nootropics. Both need independent replication, transparent product characterization, and stronger safety evidence.

Decision field	Semax	Selank
Human research	Limited regional neurologic studies	Small regional anxiety studies
Primary research	Stroke, neurotrophic signaling, cognition	Anxiety, neurotransmission, neuroimmune signaling
Peptide class	ACTH-derived analog	Tuftsin analog
FDA status	Not approved; compounding concerns	Not approved; compounding concerns
Evidence confidence	Low	Low

SOURCES

Semax vs Selank sources.

Human trial / 2018Semax in acute ischemic strokePubMed FDA / 2026Bulk substances that may present significant safety risksU.S. FDA WADA / 20262026 Prohibited ListWorld Anti-Doping Agency Human trial / 2008Selank compared with medazepam in anxiety disordersPubMed Review / 2018Selank pharmacology and research reviewPubMed FDA / 2026Bulk substances that may present significant safety risksU.S. FDA

Semax vs Selank: the main difference.

Semax vs Selank sources.

Questions related to Semax vs Selank.

Compare the next decision.